Brain abscess: Difference between revisions
From IDWiki
(→) |
m (Text replacement - " species]]" to "]]") |
||
Line 4: | Line 4: | ||
*Direct spread (50%) |
*Direct spread (50%) |
||
**'''Nose/sinuses:''' [[Streptococcus |
**'''Nose/sinuses:''' [[Streptococcus]] (especially [[Streptococcus anginosus group]]), [[Haemophilus]], [[Bacteroides]], [[Fusobacterium]] |
||
**'''Teeth:''' [[Streptococcus |
**'''Teeth:''' [[Streptococcus]], [[Bacteroides]], [[Prevotella]], [[Fusobacterium]], [[Haemophilus]] |
||
**'''Ears:''' [[Enterobacteriaceae]], [[Streptococcus |
**'''Ears:''' [[Enterobacteriaceae]], [[Streptococcus]], [[Pseudomonas aeruginosa]], [[Bacteroides]] |
||
*Hematogenous spread (25%) |
*Hematogenous spread (25%) |
||
**'''Lungs:''' [[Streptococcus |
**'''Lungs:''' [[Streptococcus]], [[Fusobacterium]], [[Actinomyces]] |
||
**'''Urinary tract:''' [[Pseudomonas aeruginosa]], [[Enterobacter |
**'''Urinary tract:''' [[Pseudomonas aeruginosa]], [[Enterobacter]] |
||
**'''Endocarditis:''' [[Viridans group streptococci]], [[Staphylococcus aureus]] |
**'''Endocarditis:''' [[Viridans group streptococci]], [[Staphylococcus aureus]] |
||
**'''Congenital cardiac malformations''' (especially right-to-left shunts): [[Streptococcus |
**'''Congenital cardiac malformations''' (especially right-to-left shunts): [[Streptococcus]] |
||
*Direct inoculation (10%) |
*Direct inoculation (10%) |
||
**'''Penetrating head trauma:''' [[Staphylococcus aureus]], [[Enterobacter |
**'''Penetrating head trauma:''' [[Staphylococcus aureus]], [[Enterobacter]], [[Clostridium]] |
||
**'''Neurosurgery:''' [[Staphylococcus |
**'''Neurosurgery:''' [[Staphylococcus]], [[Streptococcus]], [[Pseudomonas aeruginosa]], [[Enterobacter]] |
||
*Cryptogenic (15%) |
*Cryptogenic (15%) |
||
*Immunocompromised patient |
*Immunocompromised patient |
||
**'''HIV:''' [[Toxoplasma gondii]], [[Nocardia |
**'''HIV:''' [[Toxoplasma gondii]], [[Nocardia]], [[non-tuberculous mycobacteria]], [[Listeria monocytogenes]], [[Cryptococcus neoformans]] |
||
**'''Neutropenia:''' Gram-negative bacilli, [[Aspergillus |
**'''Neutropenia:''' Gram-negative bacilli, [[Aspergillus]], [[mucormycosis]], [[Candida]], [[Scedosporium]] |
||
**'''Transplantation:''' [[Aspergillus |
**'''Transplantation:''' [[Aspergillus]], [[Candida]], [[mucormycosis]], [[Scedosporium]], [[Enterobacteriaceae]], [[Nocardia]], [[Toxoplasma gondii]], and [[Mycobacterium tuberculosis]] |
||
*Plus '''[[anaerobes]]''', which are common |
*Plus '''[[anaerobes]]''', which are common |
||
*Other organisms: [[Nocardia |
*Other organisms: [[Nocardia]], [[Klebsiella pneumoniae]] (especially southeast Asia), [[Aspergillus]], [[Taenia solium]], and [[Toxoplasma gondii]] |
||
===Pathophysiology=== |
===Pathophysiology=== |
Latest revision as of 16:44, 25 January 2022
Background
Microbiology
- Direct spread (50%)
- Nose/sinuses: Streptococcus (especially Streptococcus anginosus group), Haemophilus, Bacteroides, Fusobacterium
- Teeth: Streptococcus, Bacteroides, Prevotella, Fusobacterium, Haemophilus
- Ears: Enterobacteriaceae, Streptococcus, Pseudomonas aeruginosa, Bacteroides
- Hematogenous spread (25%)
- Lungs: Streptococcus, Fusobacterium, Actinomyces
- Urinary tract: Pseudomonas aeruginosa, Enterobacter
- Endocarditis: Viridans group streptococci, Staphylococcus aureus
- Congenital cardiac malformations (especially right-to-left shunts): Streptococcus
- Direct inoculation (10%)
- Penetrating head trauma: Staphylococcus aureus, Enterobacter, Clostridium
- Neurosurgery: Staphylococcus, Streptococcus, Pseudomonas aeruginosa, Enterobacter
- Cryptogenic (15%)
- Immunocompromised patient
- HIV: Toxoplasma gondii, Nocardia, non-tuberculous mycobacteria, Listeria monocytogenes, Cryptococcus neoformans
- Neutropenia: Gram-negative bacilli, Aspergillus, mucormycosis, Candida, Scedosporium
- Transplantation: Aspergillus, Candida, mucormycosis, Scedosporium, Enterobacteriaceae, Nocardia, Toxoplasma gondii, and Mycobacterium tuberculosis
- Plus anaerobes, which are common
- Other organisms: Nocardia, Klebsiella pneumoniae (especially southeast Asia), Aspergillus, Taenia solium, and Toxoplasma gondii
Pathophysiology
- Either from contiguous spread from a head and neck infection, hematogenous spread from bacteremia or endocarditis, traumatic inoculation, or post-neurosurgery
- Typically starts as a small focus of infection in the brain parenchyma, followed by cerebritis and eventual capsule formation to give an abscess
- Microbiology (above) depends on mechanism of infection
Clinical Manifestations
- Often non-specific
- Headache is most common, then fever and focal neurological deficits
- May have seizures
- May have symptoms of increase ICP, such as comiting, blurry vision, drowiness, and confusion
Prognosis and Complications
- 10% mortality
- 50% seizures
- 20% significant cognitive impairment
Investigations
- MRI with gadolinium
- Typically demonstrates a ring-enhancing lesion with thin rim
- Temporal lobe and cerebellum suggests contiguous spread from chronic otitis or mastoiditis
- Frontal and temporal lobe suggests contiguous spread from frontal or ethmoid sinusitis
- Frontal lobe and cerebellum can be secondary to meningitis
- Frontal lobe scan be from dental infection or manipulation
- Multiple abscesses in a middle cerebral artery distribution suggests bacteremia
- Blood cultures positive in 15%
- Lumbar puncture usually contraindicated due to mass effect and risk of herniation
- Most important is aspiration of abscess for stain and culture, which is positive in 2/3 of cases
- Can do bacterial or fungal ribosomal PCR if cultures negative
Management
- Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread)
- For likely oral, ear, or sinus source, treated with ceftriaxone and metronidazole at CNS doses
- For likely hematogenous spread, treated with vancomycin
- For uncertain etiology, combination of ceftriaxone, metronidazole, and vancomycin
- For neurosurgical patients, vancomycin plus a broad-spectrum antipseudomonal antibiotic such as ceftazidime, cefepime, or meropenem
- Source control with neurosurgical aspiration
- Duration is typically 6 to 8 weeks of intravenous antibiotics following source control
- Monitor with serial MRI, though abnormalities may persist after successful treatment
- No role for routine use of steroids
Further Reading
- Brain Abscesses. NEJM. 2015;371:447-456. doi: 10.1056/NEJMra1301635